These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38695963)

  • 1. Novel biomarkers and psoriasis associated cardiovascular risk.
    Fernández-Domper L; Martin-Hernández JM; Páramo JA; Fernandez-Alonso L; Martínez-Casimiro L; Montesinos-Villaescusa E; Revert-Fernández Á; Morales-Suarez-Varela M
    Arch Dermatol Res; 2024 May; 316(5):140. PubMed ID: 38695963
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?
    Sunbul M; Agirbasli M
    Curr Pharm Des; 2014; 20(4):529-35. PubMed ID: 23565636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
    Joshi AA; Lerman JB; Aberra TM; Afshar M; Teague HL; Rodante JA; Krishnamoorthy P; Ng Q; Aridi TZ; Salahuddin T; Natarajan B; Lockshin BN; Ahlman MA; Chen MY; Rader DJ; Reilly MP; Remaley AT; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
    Circ Res; 2016 Nov; 119(11):1242-1253. PubMed ID: 27654120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk.
    Conforti C; Currado D; Navarini L; Retrosi C; Giuffrida R; Zelin E; Afeltra A; di Meo N; Dianzani C; Zalaudek I
    Dermatol Ther; 2020 Nov; 33(6):e14451. PubMed ID: 33098612
    [No Abstract]   [Full Text] [Related]  

  • 5. Discordance between estimated cardiovascular risk and subclinical atherosclerosis in psoriasis: when seeing helps believing.
    Islam SJ; Mehta A
    Eur J Prev Cardiol; 2022 Mar; 29(4):588-590. PubMed ID: 33624007
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States.
    Song WB; Peck GM; Neopaney A; Shin DB; Fleischer AB; Feldman SR; Gelfand JM
    J Invest Dermatol; 2023 Sep; 143(9):1816-1819. PubMed ID: 36990175
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
    Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
    Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis.
    Sunitha S; Rajappa M; Thappa DM; Chandrashekar L; Munisamy M; Revathy G; Priyadarssini M
    Indian J Dermatol Venereol Leprol; 2015; 81(5):464-71. PubMed ID: 26323680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis.
    Näslund-Koch C; Vedel-Krogh S; Bojesen SE; Skov L
    Acta Derm Venereol; 2022 Oct; 102():adv00789. PubMed ID: 36121209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malondialdehyde, lipoprotein-a, lipoprotein ratios, comprehensive lipid tetrad index and atherogenic index as surrogate markers for cardiovascular disease in patients with psoriasis: a case-control study.
    Wadhwa D; Mahajan VK; Mehta KS; Chauhan PS; Yadav RS; Bhushan S; Sharma V; Sharma A; Sharma A; Chauhan S
    Arch Dermatol Res; 2019 May; 311(4):287-297. PubMed ID: 30830310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis.
    Jensen P; Zachariae C; Christensen R; Geiker NR; Schaadt BK; Stender S; Astrup A; Hansen PR; Skov L
    Acta Derm Venereol; 2014 Nov; 94(6):691-4. PubMed ID: 24556829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis.
    Kim NY; Back JH; Shin JH; Ji MJ; Lee SJ; Park YE; Park HM; Gu MB; Lee JE; Kim JE
    Sci Rep; 2023 Feb; 13(1):2869. PubMed ID: 36804462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial commentary: Psoriasis, inflammation and cardiometabolic disease. Will we ever get to the heart of the matter?
    Garshick MS
    Trends Cardiovasc Med; 2020 Nov; 30(8):479-480. PubMed ID: 31810858
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions.
    Sunbul M; Seckin D; Durmus E; Ozgen Z; Bozbay M; Bozbay A; Kivrak T; Oguz M; Sari I; Ergun T; Agirbasli M
    Heart Vessels; 2015 May; 30(3):347-54. PubMed ID: 24633494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of cardiovascular risk factors in patients with psoriasis: A Danish nationwide study.
    Liljendahl MS; Loft N; Passey A; Wegner S; Egeberg A; Skov L
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):e608-e610. PubMed ID: 36648140
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune diseases and cardiovascular risk.
    Gelfand JM; Wang S; Garshick MS
    Trends Mol Med; 2022 Dec; 28(12):1025-1027. PubMed ID: 36357282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic cardiovascular involvement in psoriasis: a systematic review.
    Mosca S; Gargiulo P; Balato N; Di Costanzo L; Parente A; Paolillo S; Ayala F; Trimarco B; Crea F; Perrone-Filardi P
    Int J Cardiol; 2015 Jan; 178():191-9. PubMed ID: 25464252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease-Associated Skin Conditions.
    Hojman L; Karsulovic C
    Vasc Health Risk Manag; 2022; 18():43-53. PubMed ID: 35210782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.